Drug Detail:Pimavanserin (Pimavanserin [ pim-a-van-ser-in- ])
Drug Class: Atypical antipsychotics
Pimavanserin Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the clinical use of pimavanserin during breastfeeding. If pimavanserin is required by the mother, it is not a reason to discontinue breastfeeding. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Haloperidol, Olanzapine, Quetiapine, Risperidone
Substance Identification
Substance Name
Pimavanserin
CAS Registry Number
706779-91-1
Drug Class
Breast Feeding
Lactation
Milk, Human
Antiparkinson Agents
Antipsychotic Agents
Serotonin 5-HT2 Receptor Antagonists
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification